Cargando…
Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
BACKGROUND: Oxidative stress is involved in the progression of Parkinson’s disease (PD). Recent studies have confirmed that molecular hydrogen (H(2)) functions as a highly effective antioxidant in animal models of PD. A placebo-controlled, randomized, double-blind, parallel-group clinical pilot stud...
Autores principales: | Yoritaka, Asako, Kobayashi, Yasuko, Hayashi, Tetsuo, Saiki, Shinji, Hattori, Nobutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519836/ https://www.ncbi.nlm.nih.gov/pubmed/34319514 http://dx.doi.org/10.1007/s10072-021-05489-4 |
Ejemplares similares
-
Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson's Disease
por: Yoritaka, Asako, et al.
Publicado: (2022) -
A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
por: Yoritaka, Asako, et al.
Publicado: (2016) -
Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
por: Yoritaka, Asako, et al.
Publicado: (2017) -
Inhalation of hydrogen gas elevates urinary 8-hydroxy-2′-deoxyguanine in Parkinson’s disease
por: Hirayama, Masaaki, et al.
Publicado: (2019) -
Motor/Nonmotor Symptoms and Progression in Patients with Parkinson's Disease: Prevalence and Risks in a Longitudinal Study
por: Yoritaka, Asako, et al.
Publicado: (2020)